Aurobindo Pharma consolidated net profit declines 5.68% in the March 2021 quarter

Sales decline 1.18% to Rs 5991.68 crore

Net profit of Aurobindo Pharma declined 5.68% to Rs 801.58 crore in the quarter ended March 2021 as against Rs 849.83 crore during the previous quarter ended March 2020. Sales declined 1.18% to Rs 5991.68 crore in the quarter ended March 2021 as against Rs 6063.40 crore during the previous quarter ended March 2020.

For the full year,net profit rose 88.45% to Rs 5334.85 crore in the year ended March 2021 as against Rs 2830.97 crore during the previous year ended March 2020. Sales rose 8.00% to Rs 24557.95 crore in the year ended March 2021 as against Rs 22737.95 crore during the previous year ended March 2020.

 

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales5991.686063.40 -1 24557.9522737.95 8 OPM %21.1321.39 -21.4921.15 - PBDT1326.181297.67 2 5584.404735.86 18 PBT1060.181065.26 0 4529.023769.15 20 NP801.58849.83 -6 5334.852830.97 88

Powered by Capital Market - Live News